|
GB202018468D0
|
|
New therapy
|
|
GB201912191D0
|
|
New therapy
|
|
GB201818579D0
|
|
New therapy
|
|
GB201807312D0
|
|
Formulation
|
|
GB201720808D0
|
|
Formulation
|
|
GB201707501D0
|
|
New therapy 2
|
|
GB201707503D0
|
|
New Therapy 3
|
|
GB201707500D0
|
|
New therapy
|
|
AU2012200661A1
|
|
Immunostimulatory method
|
|
WO2012084991A1
|
|
Biologically active oligonucleotides capable of modulating the immune system ii
|
|
EP2655622A2
|
|
Methods for identifying biologically active oligonucleotides capable of modulating the immune system
|
|
EP2596806A1
|
|
Method for prevention of colectomy
|
|
EP2468867A1
|
|
Methods for identifying biologically active oligonucleotides capable of modulating the immune system
|
|
EP2468866A1
|
|
Biologically active oligonucleotides capable of modulating the immune system
|
|
EP2350283A2
|
|
Compounds and methods for the treatment of inflammatory diseases of the cns
|
|
WO2010053433A1
|
|
Increased expression of specific antigens
|
|
WO2010053430A1
|
|
Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells
|
|
WO2009154565A1
|
|
Combination therapies against cancer
|
|
AU2008339090A1
|
|
Method for predicting the response to a therapy
|
|
EP2207555A1
|
|
Oligonucleotides for the treatment or alleviation of edema
|
